PortfoliosLab logo
AZN vs. UNH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AZN and UNH is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

AZN vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AstraZeneca PLC (AZN) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

AZN:

-0.38

UNH:

-1.00

Sortino Ratio

AZN:

-0.36

UNH:

-1.18

Omega Ratio

AZN:

0.95

UNH:

0.79

Calmar Ratio

AZN:

-0.32

UNH:

-0.76

Martin Ratio

AZN:

-0.56

UNH:

-2.74

Ulcer Index

AZN:

15.80%

UNH:

15.44%

Daily Std Dev

AZN:

23.25%

UNH:

43.33%

Max Drawdown

AZN:

-48.94%

UNH:

-82.68%

Current Drawdown

AZN:

-20.37%

UNH:

-52.93%

Fundamentals

Market Cap

AZN:

$213.34B

UNH:

$264.80B

EPS

AZN:

$2.48

UNH:

$25.43

PE Ratio

AZN:

27.75

UNH:

11.48

PEG Ratio

AZN:

0.92

UNH:

0.59

PS Ratio

AZN:

3.88

UNH:

0.65

PB Ratio

AZN:

5.20

UNH:

2.62

Total Revenue (TTM)

AZN:

$54.98B

UNH:

$407.42B

Gross Profit (TTM)

AZN:

$44.75B

UNH:

$87.53B

EBITDA (TTM)

AZN:

$17.70B

UNH:

$31.08B

Returns By Period

In the year-to-date period, AZN achieves a 6.49% return, which is significantly higher than UNH's -42.05% return. Both investments have delivered pretty close results over the past 10 years, with AZN having a 10.64% annualized return and UNH not far ahead at 10.90%.


AZN

YTD

6.49%

1M

1.81%

6M

10.35%

1Y

-8.71%

5Y*

7.65%

10Y*

10.64%

UNH

YTD

-42.05%

1M

-35.72%

6M

-50.31%

1Y

-43.47%

5Y*

1.38%

10Y*

10.90%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AZN vs. UNH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AZN
The Risk-Adjusted Performance Rank of AZN is 3030
Overall Rank
The Sharpe Ratio Rank of AZN is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of AZN is 2525
Sortino Ratio Rank
The Omega Ratio Rank of AZN is 2525
Omega Ratio Rank
The Calmar Ratio Rank of AZN is 3030
Calmar Ratio Rank
The Martin Ratio Rank of AZN is 3939
Martin Ratio Rank

UNH
The Risk-Adjusted Performance Rank of UNH is 55
Overall Rank
The Sharpe Ratio Rank of UNH is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of UNH is 99
Sortino Ratio Rank
The Omega Ratio Rank of UNH is 55
Omega Ratio Rank
The Calmar Ratio Rank of UNH is 66
Calmar Ratio Rank
The Martin Ratio Rank of UNH is 00
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AZN vs. UNH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current AZN Sharpe Ratio is -0.38, which is higher than the UNH Sharpe Ratio of -1.00. The chart below compares the historical Sharpe Ratios of AZN and UNH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

AZN vs. UNH - Dividend Comparison

AZN's dividend yield for the trailing twelve months is around 2.22%, less than UNH's 2.88% yield.


TTM20242023202220212020201920182017201620152014
AZN
AstraZeneca PLC
2.22%2.27%2.15%2.14%2.40%2.80%2.81%3.61%3.95%5.01%4.06%3.98%
UNH
UnitedHealth Group Incorporated
2.88%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%1.39%

Drawdowns

AZN vs. UNH - Drawdown Comparison

The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum UNH drawdown of -82.68%. Use the drawdown chart below to compare losses from any high point for AZN and UNH. For additional features, visit the drawdowns tool.


Loading data...

Volatility

AZN vs. UNH - Volatility Comparison

The current volatility for AstraZeneca PLC (AZN) is 8.42%, while UnitedHealth Group Incorporated (UNH) has a volatility of 33.07%. This indicates that AZN experiences smaller price fluctuations and is considered to be less risky than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

AZN vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between AstraZeneca PLC and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20212022202320242025
13.59B
109.58B
(AZN) Total Revenue
(UNH) Total Revenue
Values in USD except per share items

AZN vs. UNH - Profitability Comparison

The chart below illustrates the profitability comparison between AstraZeneca PLC and UnitedHealth Group Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
83.5%
21.7%
(AZN) Gross Margin
(UNH) Gross Margin
AZN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported a gross profit of 11.35B and revenue of 13.59B. Therefore, the gross margin over that period was 83.5%.

UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a gross profit of 23.77B and revenue of 109.58B. Therefore, the gross margin over that period was 21.7%.

AZN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported an operating income of 3.67B and revenue of 13.59B, resulting in an operating margin of 27.0%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported an operating income of 9.12B and revenue of 109.58B, resulting in an operating margin of 8.3%.

AZN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported a net income of 2.92B and revenue of 13.59B, resulting in a net margin of 21.5%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a net income of 6.29B and revenue of 109.58B, resulting in a net margin of 5.7%.